Job Watch

Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-21-248 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to correlate immune systemdevelopment patterns between two or more age groups- neonates, infants, and children and adolescents and further understand the impact of infectious diseases, microbiome and environmental factors on ontogeny and development of pediatric immune system, from birth, transitioning into adolescence and adulthood with focus impact during pregnancy and post-natal period.

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)

Funding Opportunity PAR-21-281 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites basic and/or methodological research projects that seek to illuminate or measure independent and interdependent health-related effects within dyads. For the purpose of this FOA, a dyad is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks. Both animal and human subjects research projects are welcome. Types of projects submitted under this FOA include but are not limited to, studies observational studies involving humans, or existing/synthesized datasets studies. Applications proposing studies that prospectively assign human participants to conditions meet the NIH definition of basic research and fall within the NIH definition of clinical trials (see, e.g., NOT-OD-19-024). Researchers proposing basic science experimental studies involving human participants (i.e., experimentally manipulate independent variables) should consider the companion FOA PAR-XX-XXX "Dyadic Interpersonal Processes and Biopsychosocial outcomes (R01 Basic Experimental Studies with Humans).

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)

Funding Opportunity PAR-21-280 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites basic and/or methodological research projects that seek to illuminate or measure independent and interdependent health-related effects within dyads. For the purpose of this FOA, a dyad is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects that emanate from intra-dyadic phenomena. NIH considers such studies as prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of clinical trials (see, e.g., NOT-OD-19-024). Applications proposing studies using model animal research, observational studies involving humans, or existing/synthesized datasets should submit under the companion FOA PAR-XX-XXX " Dyadic interpersonal processes and biopsychosocial outcomes (R01 Clinical Trials Not Allowed).

Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)

Funding Opportunity RFA-HG-21-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)

Funding Opportunity RFA-HG-21-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-21-050 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement solicits applications to establish the Antiviral Drug Discovery (AViDD) program of multidisciplinary Centers focused on discovery and development of antivirals against coronaviruses (CoVs) and select RNA viruses with pandemic potential. Through this program, NIAID will encourage the development of antivirals that are effective against multiple viruses, technologies that can be widely applied to improve classes of antivirals, and platforms that can reduce the time and cost of creating new antivirals.

Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)

Funding Opportunity RFA-DA-23-001 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support projects that further develop or exploit advances using in situ or in vivo imaging or related technologies to investigate HIV/SIV infection, latent reservoirs, the pathogenic consequences of HIV/SIV infection, or the effects of HIV/SIV or substance use disorder (SUD) therapies. Applicants may propose primate or human studies to investigate blood, lymphoid, or brain tissues.

F. Hoffmann-La Roche AG: Senior Research Associate in Systems Biology, I2O DTA, pRED (80-100%)

New Scientist - Bioinformatics - Thu, 2021-07-08 13:38
Competitive Salary: F. Hoffmann-La Roche AG: At Roche, over 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s le Switzerland (CH)
Categories: Job Watch

EMBL: Operations Officer

New Scientist - Bioinformatics - Thu, 2021-07-08 12:27
Competitive Salary: EMBL: Training is a core activity across EMBL-EBI, involving almost every part of the organisation and coordinated by a team of 28 people. The Training Team Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Ensembl Variation Project Leader

New Scientist - Bioinformatics - Thu, 2021-07-08 12:24
Competitive Salary: EMBL: The Ensembl Project, based at the European Bioinformatics Institute (EMBL-EBI), is one of the leading providers of genome annotation. The Ensembl Tea Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Storage Engineer

New Scientist - Bioinformatics - Thu, 2021-07-08 12:23
Competitive Salary: EMBL: We are seeking a Storage professional to join our Storage team within our Technical Services Cluster (TSC), serving an institute of over 800 researche Hinxton, Cambridgeshire, England
Categories: Job Watch

Updated Process for Requesting Drawdowns Outside of the Liquidation Period

Notice NOT-OD-21-149 from the NIH Guide for Grants and Contracts

NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials)

Funding Opportunity PAR-21-239 from the NIH Guide for Grants and Contracts. Reissue of PAR-18-755. The primary goal of the NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22) Program (hereafter abbreviated as the NIMH Career Transition K22 Program) is to provide support for career intramural investigators at NIMH who aim to transition from the Division of Intramural Research Programs (DIRP) to an independent research faculty position in the extramural community. Applicants should have a demonstrated record of meritorious research in mental health-related fields

Pages

Subscribe to Anil Jegga aggregator - Job Watch